About this trial
The goal of this study is to test an electronic health (eHealth) mindfulness-based music therapy intervention to improve health-related quality of life and reduce symptom burden and disease activity in patients undergoing stem cell transplantation.
Eligibility criteria
Qualifiers
≥ 18 years of age
have a primary diagnosis of a hematologic malignancy (e.g., myelodysplastic syndrome [MDS], acute myeloid leukemia [AML], acute lymphoblastic leukemia [ALL], or non Hodgkin's Lymphoma [NHL])
have a treatment plan for a hematopoietic stem cell transplant
Speak English or Spanish
Disqualifiers
history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months)
severe cognitive impairment (per the short portable mental status questionnaire)
hearing impairment
active alcohol or substance dependence within the past six months
Trial design
Treatments tested in this trial
- eHealth Mindfulness-based Music Therapy (eMBMT)
- eHealth Mindfulness Meditation (eMM)
Treatment groups
Sponsors and collaborators
University of Miami
Lead sponsor
National Cancer Institute (NCI)
Collaborator